Evidence map›Paper›PMID 34398500›Full record

ReviewDermatologic therapy2021

Nails and COVID-19 - A comprehensive review of clinical findings and treatment.

Uwe Wollina, Jean Kanitakis, Robert Baran

Abstract readReview
In one paragraph

Review in Dermatologic therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Onychomadesis in a COVID-19 patient.Wiener medizinische Wochenschrift (1946) · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Uwe WollinaDepartment of Dermatology and Allergology, Städtisches Klinikum Dresden, Dresden, Germany.ORCID https://orcid.org/0000-0001-5933-2913
Jean KanitakisDermatology Department, Edouard Herriot Hospital Group, (Pav. R), Hospices Civils de Lyon, Lyon, France.
Robert BaranDermatology, Nail Disease Center, Cannes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 infection, responsible for COVID-19, has raised the interest for infection-associated muco-cutaneous symptoms. While dermatologic symptoms in general gained an increasing awareness, affection of the nail organ has been mentioned only recently. We provide a narrative review on COVID-19 manifestation on the nail organ and add symptoms induced by personal protective measures and SARS-CoV-2 vaccination. Available treatment options are discussed.

Indexed as

COVID-19COVID-19 VaccinesHumansNailsSARS-CoV-2SkinCOVID-19 VaccinesCOVID-19COVID-vaccinationnail diseasesnail organprotective measuresSARS-CoV-2treatment

Identifiers

PMID34398500
PMCPMC8420555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.